Welcome to our dedicated page for Gentherm news (Ticker: THRM), a resource for investors and traders seeking the latest updates and insights on Gentherm stock.
Gentherm Inc. reports developments in thermal management and pneumatic comfort technologies for automotive and medical markets. Its Automotive products include Climate Control Seats (CCS®), Climate Control Interiors (CCI™), Lumbar and Massage Comfort Solutions, Valve Systems, cable systems, battery performance solutions, and automotive electronics and software systems. Its Medical business covers patient temperature management systems and related device technology.
Recurring news includes quarterly and annual results, conference participation, automotive new-business activity, shareholder voting matters, and medical-device regulatory updates. Company announcements also cover ThermAffyx™ Patient Safety System, an integrated patient warming and securement system submitted through the FDA 510(k) pathway, and communications activity around Gentherm Medical products.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Gentherm (NASDAQ:THRM) announced its first-quarter 2023 financial results, reporting a record revenue of $363.6 million, a 35.9% increase from $267.7 million in Q1 2022. Automotive revenues rose 36.8% year over year, while new automotive awards secured totaled $480 million. Adjusted diluted earnings per share improved to $0.49, up from $0.41 in the same quarter last year. Despite these strong figures, GAAP diluted EPS decreased to $0.24 from $0.35 year-over-year. The company reaffirmed its full-year 2023 guidance, anticipating product revenues between $1.45 billion and $1.55 billion. Gentherm's gross margin faced a decline to 22.3% from 24.0%, attributed to inflation and the acquisition of Alfmeier.
Gentherm (NASDAQ: THRM), a leader in innovative thermal management technologies for the automotive sector and medical temperature management, will announce its first-quarter 2023 financial results on April 27, 2023, at 6 am ET. A conference call discussing these results will follow at 8 am ET. The call can be accessed via a toll-free number or through a live webcast available on Gentherm's website. A telephonic replay of the call will also be provided shortly after, valid until May 11, 2023. The company continues to drive advancements in automotive products, including heated seats and climate control systems, and is expanding its medical product offerings. Gentherm operates globally with over 14,000 employees, emphasizing its commitment to innovation in both automotive and medical applications.
Summary not available.
Summary not available.
Gentherm (NASDAQ:THRM) reported a record annual revenue of $1.2 billion for 2022, a 15.2% increase from 2021. The company secured new automotive business awards totaling $1.8 billion and achieved a fourth quarter revenue of $343.3 million, up 38.3% year over year. However, GAAP diluted loss per share was $(0.13), compared to earnings of $0.60 in the previous year. Adjusted diluted EPS for 2022 was $1.82, down from $3.01 in 2021. The company anticipates 2023 product revenues between $1.45 billion and $1.55 billion, with an adjusted EBITDA margin of 11.5% to 13.5%.